• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌基因、原癌基因和肿瘤干细胞的谱系限制。

Oncogenes, Proto-Oncogenes, and Lineage Restriction of Cancer Stem Cells.

机构信息

Institute of Clinical Sciences, School of Biomedical Sciences, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.

出版信息

Int J Mol Sci. 2021 Sep 7;22(18):9667. doi: 10.3390/ijms22189667.

DOI:10.3390/ijms22189667
PMID:34575830
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8470404/
Abstract

In principle, an oncogene is a cellular gene (proto-oncogene) that is dysfunctional, due to mutation and fusion with another gene or overexpression. Generally, oncogenes are viewed as deregulating cell proliferation or suppressing apoptosis in driving cancer. The cancer stem cell theory states that most, if not all, cancers are a hierarchy of cells that arises from a transformed tissue-specific stem cell. These normal counterparts generate various cell types of a tissue, which adds a new dimension to how oncogenes might lead to the anarchic behavior of cancer cells. It is that stem cells, such as hematopoietic stem cells, replenish mature cell types to meet the demands of an organism. Some oncogenes appear to deregulate this homeostatic process by restricting leukemia stem cells to a single cell lineage. This review examines whether cancer is a legacy of stem cells that lose their inherent versatility, the extent that proto-oncogenes play a role in cell lineage determination, and the role that epigenetic events play in regulating cell fate and tumorigenesis.

摘要

原则上,癌基因是一种细胞基因(原癌基因),由于突变和与另一个基因融合或过度表达而失去功能。通常,癌基因被视为通过调节细胞增殖或抑制细胞凋亡来驱动癌症。癌症干细胞理论指出,大多数(如果不是全部)癌症是一种细胞层次结构,它起源于转化的组织特异性干细胞。这些正常的对应物产生组织的各种细胞类型,这为癌基因如何导致癌细胞的混乱行为增添了一个新的维度。正是干细胞,如造血干细胞,通过补充成熟的细胞类型来满足生物体的需求。一些癌基因似乎通过限制白血病干细胞到单一细胞谱系来调节这种体内平衡过程。这篇综述探讨了癌症是否是干细胞失去内在多功能性的遗留物,原癌基因在细胞谱系决定中所起的作用,以及表观遗传事件在调节细胞命运和肿瘤发生中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a729/8470404/41278ce7e0f0/ijms-22-09667-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a729/8470404/5ca16413f681/ijms-22-09667-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a729/8470404/41278ce7e0f0/ijms-22-09667-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a729/8470404/5ca16413f681/ijms-22-09667-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a729/8470404/41278ce7e0f0/ijms-22-09667-g002.jpg

相似文献

1
Oncogenes, Proto-Oncogenes, and Lineage Restriction of Cancer Stem Cells.癌基因、原癌基因和肿瘤干细胞的谱系限制。
Int J Mol Sci. 2021 Sep 7;22(18):9667. doi: 10.3390/ijms22189667.
2
The Making of Leukemia.白血病的形成。
Int J Mol Sci. 2018 May 17;19(5):1494. doi: 10.3390/ijms19051494.
3
Tracing the cellular origin of cancer.追踪癌症的细胞起源。
Nat Cell Biol. 2013 Feb;15(2):126-34. doi: 10.1038/ncb2657. Epub 2013 Jan 20.
4
Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia.微环境决定MLL - AF9白血病人类模型中的谱系命运。
Cancer Cell. 2008 Jun;13(6):483-95. doi: 10.1016/j.ccr.2008.04.020.
5
Oncogenes and the Origins of Leukemias.癌基因与白血病的起源。
Int J Mol Sci. 2022 Feb 18;23(4):2293. doi: 10.3390/ijms23042293.
6
Stem cell plasticity in development and cancer: epigenetic origin of cancer stem cells.发育与癌症中的干细胞可塑性:癌症干细胞的表观遗传学起源
Subcell Biochem. 2013;61:545-65. doi: 10.1007/978-94-007-4525-4_24.
7
Are Leukaemic Stem Cells Restricted to a Single Cell Lineage?白血病干细胞是否局限于单一细胞谱系?
Int J Mol Sci. 2019 Dec 19;21(1):45. doi: 10.3390/ijms21010045.
8
Interactions of retroviral and cellular transforming genes with hematopoietic cells.逆转录病毒和细胞转化基因与造血细胞的相互作用。
Ann N Y Acad Sci. 1987;511:148-70. doi: 10.1111/j.1749-6632.1987.tb36245.x.
9
Cancer biology: a game of subversion.癌症生物学:一场颠覆的游戏。
Nature. 2006 Aug 17;442(7104):754-5. doi: 10.1038/442754a.
10
Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.作为终末造血细胞分化的正负调节因子的分化初级反应基因和原癌基因。
Stem Cells. 1994 Jul;12(4):352-69. doi: 10.1002/stem.5530120402.

引用本文的文献

1
Mitochondrial micro RNAs: Crucial players in carcinogenesis.线粒体微小RNA:癌症发生中的关键参与者。
Oncol Res. 2025 May 29;33(6):1301-1321. doi: 10.32604/or.2025.055945. eCollection 2025.
2
Cell cycle proteins: Linking the cell cycle to tumors.细胞周期蛋白:连接细胞周期与肿瘤
Oncol Res. 2025 May 29;33(6):1335-1346. doi: 10.32604/or.2025.058760. eCollection 2025.
3
Mechanisms of Antitumor Activity of Low Doses of Radiation Associated with Activation of Cells' Defense System.低剂量辐射与细胞防御系统激活相关的抗肿瘤活性机制

本文引用的文献

1
Disabling de novo DNA methylation in embryonic stem cells allows an illegitimate fate trajectory.在胚胎干细胞中抑制从头 DNA 甲基化可允许一条非合法的命运轨迹。
Proc Natl Acad Sci U S A. 2021 Sep 21;118(38). doi: 10.1073/pnas.2109475118.
2
The Second Oncogenic Hit Determines the Cell Fate of Positive Leukemia.第二次致癌打击决定了阳性白血病的细胞命运。
Front Cell Dev Biol. 2021 Jul 15;9:704591. doi: 10.3389/fcell.2021.704591. eCollection 2021.
3
Different mutant RUNX1 oncoproteins program alternate haematopoietic differentiation trajectories.
Dokl Biochem Biophys. 2025 Feb;520(1):96-100. doi: 10.1134/S160767292470128X. Epub 2025 Jan 22.
4
FAT1 knockdown enhances the CSC properties of HNSCC through p-CaMKII-mediated inactivation of the IFN pathway.FAT1基因敲低通过p-CaMKII介导的干扰素途径失活增强头颈部鳞状细胞癌的癌症干细胞特性。
Int J Biol Sci. 2025 Jan 1;21(2):671-684. doi: 10.7150/ijbs.95723. eCollection 2025.
5
Status Quo in the Liposome-Based Therapeutic Strategies Against Glioblastoma: "Targeting the Tumor and Tumor Microenvironment".基于脂质体的胶质母细胞瘤治疗策略的现状:“靶向肿瘤和肿瘤微环境”。
Int J Mol Sci. 2024 Oct 19;25(20):11271. doi: 10.3390/ijms252011271.
6
Characterization of tumor suppressors and oncogenes evaluated from TCGA cancers.从TCGA癌症数据评估肿瘤抑制基因和癌基因的特征。
Am J Clin Exp Immunol. 2024 Aug 25;13(4):187-194. doi: 10.62347/XMZW6604. eCollection 2024.
7
Harnessing Artificial Intelligence for the Detection and Management of Colorectal Cancer Treatment.利用人工智能检测和管理结直肠癌治疗。
Cancer Prev Res (Phila). 2024 Nov 4;17(11):499-515. doi: 10.1158/1940-6207.CAPR-24-0178.
8
[Clinical characteristics and prognostic implications of RAS mutations in newly diagnosed acute myeloid leukemia with normal karyotype based on next-generation sequencing analysis].基于二代测序分析的初诊核型正常急性髓系白血病中RAS突变的临床特征及预后意义
Zhonghua Xue Ye Xue Za Zhi. 2023 Sep 14;44(9):762-766. doi: 10.3760/cma.j.issn.0253-2727.2023.09.010.
9
Impact of Amplified Oncogenes on Salivary Gland Carcinomas.扩增癌基因对唾液腺癌的影响。
Cancer Diagn Progn. 2023 Sep 3;3(5):528-532. doi: 10.21873/cdp.10250. eCollection 2023 Sep-Oct.
10
Liposomes for the Treatment of Brain Cancer-A Review.用于治疗脑癌的脂质体——综述
Pharmaceuticals (Basel). 2023 Jul 25;16(8):1056. doi: 10.3390/ph16081056.
不同突变型 RUNX1 癌蛋白调控不同的造血分化轨迹。
Life Sci Alliance. 2021 Jan 4;4(2). doi: 10.26508/lsa.202000864. Print 2021 Feb.
4
Conditional expression of HGAL leads to the development of diffuse large B-cell lymphoma in mice.HGAL 的条件表达导致小鼠弥漫性大 B 细胞淋巴瘤的发生。
Blood. 2021 Apr 1;137(13):1741-1753. doi: 10.1182/blood.2020004996.
5
Dynamic regulation of histone modifications and long-range chromosomal interactions during postmitotic transcriptional reactivation.有丝分裂后转录激活过程中组蛋白修饰和长距离染色体相互作用的动态调控
Genes Dev. 2020 Jul 1;34(13-14):913-930. doi: 10.1101/gad.335794.119. Epub 2020 Jun 4.
6
Role of HDACs in normal and malignant hematopoiesis.组蛋白去乙酰化酶在正常和恶性造血中的作用。
Mol Cancer. 2020 Jan 7;19(1):5. doi: 10.1186/s12943-019-1127-7.
7
Rap1 regulates hematopoietic stem cell survival and affects oncogenesis and response to chemotherapy.Rap1 调节造血干细胞存活,并影响肿瘤发生和对化疗的反应。
Nat Commun. 2019 Dec 13;10(1):5349. doi: 10.1038/s41467-019-13082-9.
8
HDAC Inhibitors in Acute Myeloid Leukemia.急性髓系白血病中的组蛋白去乙酰化酶抑制剂
Cancers (Basel). 2019 Nov 14;11(11):1794. doi: 10.3390/cancers11111794.
9
Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia.miRNAs、circRNAs 和长链非编码 RNA 在急性髓系白血病中的作用。
J Hematol Oncol. 2019 May 24;12(1):51. doi: 10.1186/s13045-019-0734-5.
10
Oncogenic Roles and Inhibitors of DNMT1, DNMT3A, and DNMT3B in Acute Myeloid Leukaemia.DNMT1、DNMT3A和DNMT3B在急性髓系白血病中的致癌作用及抑制剂
Biomark Insights. 2019 May 8;14:1177271919846454. doi: 10.1177/1177271919846454. eCollection 2019.